PHOTOAFFINITY-LABELING AND ISOELECTRIC-FOCUSING OF THE HUMAN-PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 (TXA2/PGH2) RECEPTOR

被引:0
|
作者
MAIS, DE
HALUSHKA, PV
机构
[1] MED UNIV S CAROLINA, DEPT EXPTL THERAPEUT, CHARLESTON, SC 29425 USA
[2] MED UNIV S CAROLINA, DEPT MED, CHARLESTON, SC 29425 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:168 / 171
页数:4
相关论文
共 50 条
  • [21] CGS-23305 - INVITRO CHARACTERIZATION OF A POTENT THROMBOXANE-A PROSTAGLANDIN-H (TXA2 PGH2) RECEPTOR ANTAGONIST AND THROMBOXANE SYNTHASE INHIBITOR
    DOTSON, R
    COHEN, D
    MATHIS, J
    FURNESS, P
    LEE, W
    BHAGWAT, S
    GUDE, C
    FASEB JOURNAL, 1992, 6 (04): : A1599 - A1599
  • [22] IRREVERSIBLE ANTAGONISM OF THE TXA2/PGH2 RECEPTOR MEDIATING PLATELET-AGGREGATION IN MAN
    TAKAHARA, K
    MURRAY, R
    FITZGERALD, GA
    FITZGERALD, DJ
    CLINICAL RESEARCH, 1989, 37 (02): : A342 - A342
  • [23] BINDING OF AN I-125-LABELED THROMBOXANE A2(TXA2)/PROSTAGLANDIN H2(PGH2) RECEPTOR ANTAGONIST TO WASHED CANINE PLATELETS
    MAIS, D
    KOCHEL, P
    SAUSSY, D
    HALUSHKA, P
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1822 - 1822
  • [24] Ifetroban sodium:: An effective TxA2/PGH2 receptor antagonist
    Rosenfeld, L
    Grover, GJ
    Stier, CT
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (02): : 97 - 115
  • [25] DECREASE IN AGONIST AFFINITY FOR HUMAN-PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTORS INDUCED BY A PLATELET-DERIVED SUPERNATANT
    DORN, GW
    BURCH, RM
    KOCHEL, PJ
    MAIS, DE
    HALUSHKA, PV
    BIOCHEMICAL PHARMACOLOGY, 1987, 36 (12) : 1913 - 1917
  • [26] SPECIFIC MODULATION OF THE HUMAN PLATELET TXA2/PGH2 RECEPTOR BY EICOSAPENTAENOIC (EPA) AND DOCOSAHEXAENOIC (DHA) ACIDS
    PARENT, CA
    SWANN, PG
    VENTON, DL
    LAGARDE, M
    LEBRETON, GC
    ARTERIOSCLEROSIS, 1990, 10 (05): : A936 - A936
  • [27] INTERACTIONS OF DIHYDROPYRIDINE CA2+ CHANNEL AGONISTS WITH THE HUMAN PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTOR
    MAYEUX, PR
    MAIS, DE
    HALUSHKA, PV
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 206 (01): : 15 - 21
  • [28] COMPARISON OF VASCULAR AND PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTORS IN THE PIG
    MIHARA, S
    HARA, S
    UEDA, M
    IDE, M
    FUJIMOTO, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (03) : 313 - 321
  • [29] NEW TXA2/PGH2 RECEPTOR ANTAGONISTS BASED ON THE CARBACYCLIN SKELETON
    KLAR, U
    PLETSCH, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (02) : 199 - 204
  • [30] PLATELET THROMBOXANE A2 ENDOPEROXIDE (TXA2/PGH2) RECEPTORS IN TYPE-1 DIABETES-MELLITUS
    JASCHONEK, K
    FAUL, C
    WEISENBERGER, H
    KRONERT, K
    SCHRODER, H
    RENN, W
    THROMBOSIS AND HAEMOSTASIS, 1989, 61 (03) : 535 - 536